Skip to main content
TipRanks
Go Ultimate75% OFF

Pulse Biosciences (PLSE) Ratios

292 Followers

Pulse Biosciences Ratios

PLSE's free cash flow for Q3 2026 was $-15.41M. For the 2026 fiscal year, PLSE's free cash flow was decreased by $-142.00K and operating cash flow was $-15.27M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Mar 22
Liquidity Ratios
Current Ratio10.5311.886.7610.394.30
Quick Ratio10.5111.886.7610.393.62
Cash Ratio10.1911.746.6110.223.36
Solvency Ratio-5.17-2.98-2.77-0.71-3.37
Operating Cash Flow Ratio-6.83-3.61-4.93-7.86-6.35
Short-Term Operating Cash Flow Coverage0.000.000.00-51.27-124.08
Net Current Asset Value$ 69.54M$ 101.85M$ 30.53M$ -17.98M$ 18.07M
Leverage Ratios
Debt-to-Assets Ratio0.080.070.150.980.21
Debt-to-Equity Ratio0.090.080.21-33.790.32
Debt-to-Capital Ratio0.090.070.171.030.24
Long-Term Debt-to-Capital Ratio0.000.000.001.040.00
Financial Leverage Ratio1.171.151.33-34.641.52
Debt Service Coverage Ratio0.000.00-38.52-61.83-141.90
Interest Coverage Ratio0.000.00-39.610.000.00
Debt to Market Cap0.000.000.000.700.00
Interest Debt Per Share0.110.150.212.240.40
Net Debt to EBITDA1.022.080.83-0.260.28
Profitability Margins
Gross Profit Margin-360.00%0.00%0.00%-1606.29%-38.79%
EBIT Margin-20794.57%0.00%0.00%-8293.86%-4443.86%
EBITDA Margin-20488.57%0.00%0.00%-8100.29%-4363.05%
Operating Profit Margin-21982.57%0.00%0.00%-8293.86%-4443.86%
Pretax Profit Margin-20794.57%0.00%0.00%-8357.86%-4489.42%
Net Profit Margin-20794.57%0.00%0.00%-8357.86%-4489.42%
Continuous Operations Profit Margin-20794.57%0.00%0.00%-8357.86%-4489.42%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT94.60%95.25%96.87%100.77%101.03%
Return on Assets (ROA)-76.99%-40.45%-71.36%-75.12%-117.35%
Return on Equity (ROE)-90.24%-46.65%-95.15%2602.54%-178.37%
Return on Capital Employed (ROCE)-88.83%-45.96%-83.08%-80.75%-137.80%
Return on Invested Capital (ROIC)-87.25%-45.46%-81.44%-78.77%-134.24%
Return on Tangible Assets-79.83%-41.72%-77.48%-80.66%-131.96%
Earnings Yield-7.87%-5.27%-7.18%-62.24%-15.37%
Efficiency Ratios
Receivables Turnover1.280.000.000.0023.25
Payables Turnover0.580.000.667.590.68
Inventory Turnover11.840.000.000.000.34
Fixed Asset Turnover0.050.000.000.070.13
Asset Turnover0.000.000.000.010.03
Working Capital Turnover Ratio0.000.000.000.020.07
Cash Conversion Cycle-312.990.00-555.21-48.07557.27
Days of Sales Outstanding285.740.000.000.0015.70
Days of Inventory Outstanding30.830.000.000.001080.16
Days of Payables Outstanding629.570.00555.2148.07538.60
Operating Cycle316.580.000.000.001095.86
Cash Flow Ratios
Operating Cash Flow Per Share-0.80-0.62-0.69-1.39-1.93
Free Cash Flow Per Share-0.81-0.62-0.69-1.40-1.95
Dividend Paid and CapEx Coverage Ratio-171.82-290.74-273.07-117.24-123.79
Capital Expenditure Coverage Ratio-171.82-290.74-273.07-117.24-123.79
Operating Cash Flow Coverage Ratio-7.19-4.08-3.61-0.62-4.81
Operating Cash Flow to Sales Ratio-154.630.000.00-67.16-38.15
Free Cash Flow Yield-5.88%-3.59%-5.64%-50.44%-13.17%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-12.71-18.92-13.93-1.61-6.51
Price-to-Sales (P/S) Ratio2643.820.000.00134.29292.06
Price-to-Book (P/B) Ratio11.478.8513.25-41.8111.60
Price-to-Free Cash Flow (P/FCF) Ratio-17.00-27.88-17.73-1.98-7.59
Price-to-Operating Cash Flow Ratio-17.10-27.98-17.80-2.00-7.66
Price-to-Earnings Growth (PEG) Ratio-0.73-4.160.290.07-0.99
Enterprise Value Multiple-11.88-17.32-13.05-1.92-6.41
Enterprise Value852.13M907.57M552.76M108.82M396.78M
EV to EBITDA-11.88-17.32-13.05-1.92-6.41
EV to Sales2434.670.000.00155.45279.82
EV to Free Cash Flow-15.65-24.89-16.67-2.30-7.28
EV to Operating Cash Flow-15.74-24.97-16.73-2.31-7.33
Tangible Book Value Per Share1.151.900.83-0.221.06
Shareholders’ Equity Per Share1.201.970.92-0.071.28
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.010.000.000.020.05
Net Income Per Share-1.08-0.92-0.88-1.72-2.28
Tax Burden1.001.001.001.001.00
Interest Burden1.001.000.971.011.01
Research & Development to Revenue127.770.000.0029.7720.20
SG&A to Revenue91.510.000.0019.9413.45
Stock-Based Compensation to Revenue61.310.000.007.4210.30
Income Quality0.740.680.780.800.85

Currency in USD